Scientist
Resolian
Malvern, Pennsylvania
He had graduated Ph.D program in biomedical science at Nagasaki University, Japan. Then he pursued postdoctoral fellow to develop CAR-NK cell immunotherapy for cancer at Thomas Jefferson University. To continue for thriving, he joined Eurofins Lancaster Laboratory as a scientist in immunoassays. From 2022, he has been working as a scientist at Resolian, conducting immunoassay method development, method validation and sample analysis studies.
Disclosure information not submitted.
Problematic Aggregation of Biotinylated and Sulfo-Tagged Proteins in Immunoassays
Wednesday, October 23, 2024
3:00 PM – 3:15 PM MT